Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients
- 1 January 1992
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (10) , 1770-1771
- https://doi.org/10.1016/0959-8049(92)90092-g
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2British Journal of Cancer, 1991
- Low-dose regimen of interleukin-2 for metastatic renal carcinomaThe Lancet, 1990
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of IndomethacinJNCI Journal of the National Cancer Institute, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987